IRIS
DEIANA, Giovanni Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.237
AS - Asia 2.869
EU - Europa 2.059
SA - Sud America 1.609
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 78
OC - Oceania 10
Totale 11.945
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.136
BR - Brasile 1.424
SG - Singapore 1.144
CN - Cina 940
UA - Ucraina 599
FR - Francia 381
SE - Svezia 299
DE - Germania 262
HK - Hong Kong 244
VN - Vietnam 209
IT - Italia 155
FI - Finlandia 104
GB - Regno Unito 83
AR - Argentina 63
TR - Turchia 50
IN - India 43
MX - Messico 35
IQ - Iraq 34
RU - Federazione Russa 34
VE - Venezuela 32
BD - Bangladesh 31
CA - Canada 31
ZA - Sudafrica 31
EC - Ecuador 25
UZ - Uzbekistan 24
BE - Belgio 22
PL - Polonia 21
JP - Giappone 19
CO - Colombia 18
ES - Italia 18
NL - Olanda 18
ID - Indonesia 17
KR - Corea 16
MA - Marocco 16
CL - Cile 15
AE - Emirati Arabi Uniti 12
PK - Pakistan 12
LT - Lituania 11
PY - Paraguay 11
AT - Austria 10
NP - Nepal 10
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
JO - Giordania 9
PE - Perù 9
UY - Uruguay 8
AU - Australia 7
TN - Tunisia 7
AZ - Azerbaigian 6
HN - Honduras 6
IR - Iran 6
KE - Kenya 6
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
RO - Romania 5
BO - Bolivia 4
EU - Europa 4
GR - Grecia 4
PA - Panama 4
SY - Repubblica araba siriana 4
AL - Albania 3
BW - Botswana 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
GA - Gabon 3
HR - Croazia 3
LB - Libano 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PS - Palestinian Territory 3
RS - Serbia 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
CH - Svizzera 2
IE - Irlanda 2
JM - Giamaica 2
MD - Moldavia 2
ME - Montenegro 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BM - Bermuda 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
Totale 11.867
Salva come PNG Salva come JPEG
Città #
Dallas 1.628
Singapore 565
Chandler 537
Jacksonville 374
San Jose 318
Hong Kong 242
Ashburn 212
Beijing 195
Princeton 185
Dearborn 162
Nanjing 152
Council Bluffs 119
São Paulo 116
Columbus 106
Wilmington 93
Ho Chi Minh City 87
Lauterbourg 87
New York 84
Nanchang 69
Shanghai 63
Ann Arbor 60
Boardman 60
Los Angeles 56
Santa Clara 43
Tianjin 42
Hebei 40
Hanoi 39
Shenyang 38
Woodbridge 36
Changsha 33
Rio de Janeiro 33
Belo Horizonte 32
Rome 30
Jiaxing 26
Porto Alegre 25
Sassari 25
Denver 24
Brasília 23
Brussels 22
Baghdad 21
Buffalo 21
Campinas 21
Johannesburg 21
Tashkent 21
Curitiba 20
Munich 19
Warsaw 19
Jinan 18
Tokyo 17
Seoul 16
Bochum 15
Andover 14
Hangzhou 14
Orem 14
Da Nang 13
London 13
Ribeirão Preto 13
Salvador 13
Dhaka 12
Goiânia 12
Helsinki 12
Mexico City 12
San Francisco 12
Brooklyn 11
Caxias do Sul 11
Guangzhou 11
Izmir 11
Kunming 11
Zhengzhou 11
Atlanta 10
Guarulhos 10
Istanbul 10
Chennai 9
Duque de Caxias 9
Frankfurt am Main 9
Guayaquil 9
Ipatinga 9
Montreal 9
Norwalk 9
Phoenix 9
Sorocaba 9
Toronto 9
Volta Redonda 9
Amman 8
Amsterdam 8
Bauru 8
Campo Grande 8
Canoas 8
Caracas 8
Carapicuíba 8
Dubai 8
Florianópolis 8
Fortaleza 8
Houston 8
Itajaí 8
Manchester 8
Mauá 8
Medellín 8
Montevideo 8
Ningbo 8
Totale 6.795
Salva come PNG Salva come JPEG
Nome #
A liquid chromatography-mass spectrometry study on the spirocyclization of ninhydrin with the aminothiols 282
"Erratic" complex partial status epilepticus as a presenting feature of MELAS 210
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 200
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 196
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 196
Acute hyponatremia and neuroleptic malignant syndrome 186
Herv-k modulates the immune response in als patients 186
Beneficial effect of risperidone on behavioral disturbances associated with hyperostosis frontalis interna 180
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease 176
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 174
A simple capillary electrophoresis method for the analysis of lamotrigine in serum 173
Carbamazepine therapy for steroid psychosis 168
Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls 168
Expressive aphasia exacerbated by lamotrigine and gabapentin 164
Carbamazepine in delayed-onset cerebellar tremor 158
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 157
Beneficial effect of fluoxetine in hyperekplexia 153
Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat 152
Brain intgerstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 152
Asterixis and mild encephalopathy induced by gabapentin 152
Brain interstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 145
Brain interstitial fluid collected trhough implanted tissue cages 143
Hyperthermia, choreic dyskinesias and increased motor tone in Wernicke's encephalopathy 143
Reduced intravenous glutathione in the treatment of early Parkinson's disease 141
Brain interstitial fluid collected through implanted tissue cages 137
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 137
Attività epilettogena del tiocolchicoside nell'uomo e nel ratto wistar 135
Carbamazepine in delayed-onset cerebellar tremor 134
Determination of L-alpha aminoadipic acid levels in human and experimental epilepsy 133
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 131
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson’s Disease 131
Carbamazepine, clonazepam and focal reflex proprioceptive seizures 128
Delayedonset cerebellar tremors (DOCT): natural history and treatment 127
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 127
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 125
Neuroleptic maglignant syndrome and related syndromes in a neurological popupation 124
Tache Noire in a Patient with Acute Q Fever 123
Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia 122
Excitatory amino acids in brain interstitial fluid during sustained pentylenetetrazole-induced seizures 122
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 119
Focal e secondarily generalized convulsive status epilepticus induced by thiocolchicoside in the rat 117
Reduced intravenous glutathione in Parkinson's disease 117
Complex partial status epilepticus as presenting features of MELAS: Case report and review of literature 116
Detection of Chlamydia Pneumoniae In the CSF of Sardinian Patients With Multiple Sclerosis In The Presence Or Absence Of Oligoclonal Bands 115
Epilepsy in multiple sclerosis: Does AED resistances predict a worse outcome of disability? 114
Increase of alpha-aminoadipate in brain IF during PTZ-induced status epilepticus 113
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazole-induced convulsive status epilepticus 113
Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up 110
Intravenous glutathione in patients with Parkinson's disease 109
Epileptogenic activity of thiocolchicoside 109
MuSK antibody-positive, seronegative myasthenia gravis in two sisters 109
Encephalopathies related to antiepileptic drugs 108
Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies 108
Urine bikunin as a marker of renal impairment in Fabry's disease 107
Siti di tremore "rubrale" 107
Post-ischemic cerebellar tremors and axonal sprouting in humans 106
Ceruloplasmin and oxidative stress in multiple sclerosis 105
Cerebral and cerebellar diaschisis following carbamazepine therapy 105
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 104
Open study of the activity and tolerability of reduced intravenous glutathione in Parkinson's disease 102
Carbamazepine, clonazepam and focal reflex proprioceptives seizures 101
Intrathecal overproduction of ceruloplasmin in patients with multiple sclerosis 101
Cytokines and multiple sclerosis severity: no correlation among Sardinians 101
Ictus giovanile e Malattia di Fabry: lo stato dell’arte in Sardegna 101
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 100
Risperidone, neuroleptic malignant sindrome and probable dementia with Lewy bodies 98
Non-fluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam 98
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 98
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 97
Preliminary experience with fluoxetine in primary focal dystonias 97
Levetiracetam in stiff-person syndrome 97
Complex partial status epilepticus as presenting feature of MELAS: case report and rewiew of literature 94
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazol-induced convulsive status epilepticus 94
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation 92
Neuroleptic malignant syndrome and sudden death after combined zuclopenthixol/trihexiphenidyl withdrawal 92
Successful screening for Fabry disease in patients with juvenile stroke in North Sardinia 92
Epilepsy in multiple sclerosis: does predict a worse outcome of disability? 92
Diaschisis, "Rossi -Effect", and antiepileptic action of carbamazepine 92
Status epileptics induced by administration of thiocolchicoside to lithium-pretreated rats 91
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 91
Reduced intravenous glutathione in the treatment of early Parkinson’s Disease 90
Pharmacology of delayed-onset cerebellar tremors 90
Neurological disorders associated with Mycoplasma pneumoniae infection 89
Chronic parkinsonism after use of diquat: clinical and MRI studies 89
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges 88
Neuroleptic maglignant syndrome and related syndromes in a neurological population 86
Cerebrospinal fluid gamma-glutamyl transpeptidase in multiple sclerosis 86
Pharmacology of delayed-onset cerebellar tremors 84
Delayed-onset cerebellar tremor after stroke 82
Non – fluent spech in patients with partial epilepsy: beneficial effect of levetiracetam 82
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 81
Glycosaminoglycans and fabry’s disease 80
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 76
Discinesie bucco-linguali indotte dal fenobarbitale 75
Multiple sclerosis: correlation between cytokine production and disease progression in Sardinians 74
Familial autoimmune MuSK positive myasthenia gravis 74
Effetti avversi psichiatrici da steroidi e carbamazepina 72
Ceftriaxone has a therapeutic role in Alexander disease 68
Topiramate in patients with cerebellar tremor: a controlled trial 61
Neuroimaging leads to recognition of previously undiagnosed Fabry 49
Totale 11.899
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022360 0 12 2 19 3 0 21 31 43 17 52 160
2022/20231.070 99 58 9 176 128 196 0 115 194 12 51 32
2023/2024320 54 41 10 8 80 21 2 20 9 7 26 42
2024/20252.834 71 13 177 55 145 68 210 531 1.020 355 104 85
2025/20264.252 175 1.071 772 593 335 243 497 117 187 133 91 38
2026/2027334 97 237 0 0 0 0 0 0 0 0 0 0
Totale 11.945